{"publication_id":"2371a466-c045-460d-a766-e242574bcc65","screening":{"identified":4,"screened":4,"excluded":0,"included":4,"included_or_retained":4,"flow":["identified","screened","excluded_with_reasons","included"],"wording":"4 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit.","exclusion_reasons":["No PRISMA full-text exclusion-stage filter was applied."]},"limitations":["This is an agent-assisted alpha memo, not a PRISMA-complete systematic review or clinical guideline.","It is not PROSPERO-registered and should not be read as medical advice.","Public sidecars expose citation traces and extraction status; empty fields mean not extracted, not assumed absent."],"contradictions":["Two 2024 randomized trials in older adults define the same dose/regime but land on different ledger sides. 10.1002/ptr.8171 is a systematic review of randomized clinical trials in older adults reporting that resveratrol combined with exercise improved exercise adaptation, muscle function, and physical performance/mobility. 10.1016/j.exger.2024.112479 is the embedded dose-ranging trial that explicitly set out to test resveratrol + exercise training on trimethylamine-N-oxide in older adults with high CVD risk and observed that TMAO concentration increased over time regardless of treatment arm (p = 0.04), with each dose producing distinct metabolite signatures."]}